Background: Atrial fibrillation (AF) is the most common dysrhythmia encountered in the post-coronary artery bypass (post-CABG) patient, reported to occur with a frequency of 20–40%. To date, with the exception of amiodarone, there is no evidence that prophylactic therapy or therapy to restore and maintain sinus rhythm reduces the risk of adverse events associated with AF. Objective: To determine whether rate control alone is an effective method of managing post-CABG AF. Method: Prospective nonrandomized observational pilot study to assess the outcome of patients with post-CABG AF managed with rate control (group 1) or a combination of rate control and sinus-restoring therapy (group 2). Adverse events, postoperative length of stay, and persistence of AF were assessed in both groups at discharge and 30 days post-discharge. Results: Post-CABG AF was observed in 101 patients. Among the 39 patients in group 1 and 62 patients in group 2, there was an 87% spontaneous conversion rate to sinus rhythm at discharge (p = 0.99). The surgical length of stay was 6.3 days in group 1, and 8.3 days in group 2 (p = 0.01). Adverse events were observed in 2 patients (5.1%) in group 1, and 7 patients (11.3%) in group 2 (p = 0.29). Conclusion: Rate control appears to be an effective method of management of post-CABG AF patients, reducing length of hospital stay without increasing the rate of adverse events. Similar proportions of patients from both groups were in sinus rhythm at time of discharge, irrespective of therapeutic techniques.

Keywords:
Atrial fibrillation, Coronary artery bypass surgery, Rate control, Antiarrhythmic therapy
This content is only available via PDF.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.